Allurion Technologies, Inc. Market Cap ($21.01K)
Market Cap & Net Worth: Allurion Technologies, Inc. (ALUR)
Allurion Technologies, Inc. market cap. Allurion Technologies, Inc. (NYSE:ALUR) has a market capitalization of $21.01K ($21.01K) as of November 7, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #31780 globally and #6403 in its home market, demonstrating a -95.58% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Allurion Technologies, Inc.'s stock price $0.02 by its total outstanding shares 1000417 (1.00 Million). Also see ALUR cash generation efficiency for how efficiently the company converts equity into cash flow.
Allurion Technologies, Inc. Market Cap History (2021–2026)
Allurion Technologies, Inc. market cap history from 2021 to 2026. Data shows change from $9.73 Million to $21.01K (-66.74% CAGR). Check Allurion Technologies, Inc. share price for real-time trading data and today's change.
Allurion Technologies, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Allurion Technologies, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Allurion Technologies, Inc. growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.08x
Allurion Technologies, Inc.'s market cap is 0.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $9.73 Million | $38.24 Million | -$12.39 Million | 0.25x | N/A |
| 2022 | $10.10 Million | $64.21 Million | -$37.74 Million | 0.16x | N/A |
| 2023 | $3.74 Million | $53.47 Million | -$80.61 Million | 0.07x | N/A |
| 2024 | $430.18K | $32.11 Million | -$26.15 Million | 0.01x | N/A |
| 2025 | $1.23 Million | $15.23 Million | -$28.75 Million | 0.08x | N/A |
Competitor Companies of ALUR by Market Capitalization
Companies near Allurion Technologies, Inc. in the global market cap rankings as of November 7, 2026. Also see ALUR total asset value for a full breakdown of the balance sheet.
Key companies related to Allurion Technologies, Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Allurion Technologies, Inc. (2021–2026)
Market capitalization of Allurion Technologies, Inc. from 2021 to today. Between 2021 and today, Allurion Technologies, Inc.'s market cap moved from $9.73 Million to $ 21.01K, with a yearly change of -66.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $21.01K | -98.29% |
| 2025 | $1.23 Million | +186.05% |
| 2024 | $430.18K | -88.50% |
| 2023 | $3.74 Million | -62.97% |
| 2022 | $10.10 Million | +3.80% |
| 2021 | $9.73 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Allurion Technologies, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $21.01K USD |
| MoneyControl | $21.01K USD |
| MarketWatch | $21.01K USD |
| marketcap.company | $21.01K USD |
| Reuters | $21.01K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Allurion Technologies, Inc.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring to… Read more